Odyssey Thera's Unattributed VC Round

Odyssey Thera raised a round of funding on February 10, 2000. Investors include Burrill & Company.

Odyssey Thera offers technology that measures disease-relevant pathway activity within living human cells. Rapid identification of on-target and off-pathway activities of lead compounds enables select…

Articles about Odyssey Thera's Unattributed VC Round: